-
公开(公告)号:AU2915589A
公开(公告)日:1989-06-14
申请号:AU2915589
申请日:1988-11-08
Applicant: BAXTER INT
Inventor: BREILLATT JULIAN P , WOO LECON , NELSON DEANNA J , APPL RICHARD
-
公开(公告)号:AU7356001A
公开(公告)日:2002-02-05
申请号:AU7356001
申请日:2001-07-18
Applicant: BAXTER INT
Inventor: BREILLATT JULIAN P , STERNBERG JULIAN
-
公开(公告)号:AU617417B2
公开(公告)日:1991-11-28
申请号:AU2915589
申请日:1988-11-08
Applicant: BAXTER INT
Inventor: BREILLATT JULIAN P , WOO LECON , NELSON DEANNA J , APPL RICHARD
-
公开(公告)号:CA1339030C
公开(公告)日:1997-04-01
申请号:CA582990
申请日:1988-11-14
Applicant: BAXTER INT
Inventor: BREILLATT JULIAN P , WOO LECON , NELSON DEANNA J , APPL RICHARD
IPC: A61K9/22 , A61J3/06 , A61K47/26 , A61M1/02 , A61M1/36 , A61M5/14 , A61M31/00 , B27N3/00 , A61L33/00
Abstract: Medical solution is passed in a conduit across a solid mass of beneficial agent to cause the beneficial agent to dissolve in the medical solution. The beneficial agent comprises a sugar in a substantially anhydrous, glass form, the mass being shaped and proportioned so that a controlled amount of the beneficial agent dissolves into passing medical solution in a manner that is preferably substantially predetermined. Typically, the sugar glass of the beneficial agent includes at least one added effective agent for dissolving in the medical solution as the sugar dissolves therein.
-
-
-